Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Sales | 1,444,500 | 1,444,500 | 1,290,600 | 1,259,600 | 1,260,100 |
| Cost of Goods | 1,023,600 | 1,006,600 | 930,900 | 898,100 | 912,200 |
| Gross Profit | 420,900 | 437,900 | 359,700 | 361,500 | 347,900 |
| Operating Expenses | 236,500 | 252,400 | 240,500 | 225,400 | 225,200 |
| Operating Income | 185,000 | 185,500 | 119,200 | 136,100 | 122,700 |
| Interest Expense | 26,900 | 22,400 | 5,700 | 4,000 | 1,000 |
| Other Income | 14,900 | 34,800 | 36,200 | 10,000 | 10,400 |
| Pre-tax Income | 173,000 | 197,900 | 149,700 | 142,100 | 132,100 |
| Income Tax | 51,700 | 73,200 | 36,100 | 56,900 | -136,200 |
| Net Income Continuous | 121,300 | 121,900 | 110,200 | 100,100 | 284,200 |
| Net Income | $121,300 | $124,700 | $113,600 | $100,100 | $282,200 |
| EPS Basic Total Ops | 1.42 | 1.40 | 1.25 | 1.01 | 0.90 |
| EPS Basic Continuous Ops | 1.42 | 1.36 | 1.21 | 1.01 | 3.35 |
| EPS Diluted Total Ops | 1.37 | 1.34 | 1.20 | 1.01 | 0.72 |
| EPS Diluted Continuous Ops | 1.37 | 1.31 | 1.16 | 1.00 | 2.50 |
| EBITDA(a) | $280,100 | $272,700 | $198,000 | $225,100 | $212,600 |